Chen, Yonghe
Chen, Xiaojiang
Lin, Yi
Zhang, Shenyan
Zhou, Zhiwei
Peng, Junsheng
Funding for this research was provided by:
National Natural Science Foundation of China (82203187)
Science and Technology Planning Project of Guangzhou (202201011111)
Program of Guangdong Provincial Clinical Research Center for Digestive Diseases (2020B1111170004, 2020B1111170004)
Article History
Received: 2 November 2023
Accepted: 11 February 2024
First Online: 23 February 2024
Change Date: 6 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://0-doi-org.brum.beds.ac.uk/10.1186/s12885-024-12066-3
Declarations
:
: The study was reviewed and approved by the ethics committee of the Sixth Affiliated Hospital, Sun Yat-Sen University (Approval number: 2022ZSLYEC-020). This study was conducted in accordance with the 1964 Helsinki Declaration. Informed consents were obtained from all study participants or their legal guardians. Upon confirmation of the diagnosis, all patients (or the legal guardians) were asked for their consent to share and publish their clinical data and information for research purposes, with the assurance of privacy protection. If the patient consented and signed the form, their data would be filed in the gastrointestinal cancer database, along with the consent forms. The data used in this study were obtained from the database with approval from the ethics committee, ensuring that all patient data used had received proper consent to publish their data.
: All authors have approved the manuscript and have agreed to submit it for publication.
: Informed consents were obtained from all patients to publish their data.
: The indication for proximal gastrectomy has expanded to include patients with proximal advanced gastric cancer. However, the indication for patients following chemotherapy remained unclear. This cohort study demonstrated that for proximal gastric cancer patients that underwent neoadjuvant chemotherapy, the metastasis rate of key distal lymph node can reach 10%, rendering proximal gastrectomy an unsafe choice.
: Grade 0 (pathological complete response); Grade 1 (major response); Grade 2 (minor response); Grade 3 (no response or progression).
: The authors declare no competing interests.